Insider Sale: Director Matthew Posard Sells 29,881 Shares of Halozyme Therapeutics Inc (HALO)

By Yahoo! Finance | Aug 14, 2024 at 07:03 PM EST

Matthew Posard, Director at Halozyme Therapeutics Inc, sold 29,881 shares on August 14, 2024, bringing his total ownership to 69,874 shares. The company focuses on oncology therapies targeting the tumor microenvironment. With a market cap of $7.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.